Compare COCH & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COCH | ZTEK |
|---|---|---|
| Founded | 1995 | 2008 |
| Country | United States | Canada |
| Employees | 47 | N/A |
| Industry | Blank Checks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.0M | 59.5M |
| IPO Year | N/A | 2022 |
| Metric | COCH | ZTEK |
|---|---|---|
| Price | $0.67 | $0.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 327.4K | 138.8K |
| Earning Date | 05-08-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.58 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $0.37 |
| 52 Week High | $1.89 | $1.24 |
| Indicator | COCH | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 58.08 |
| Support Level | $0.64 | $0.55 |
| Resistance Level | $0.74 | $0.56 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 10.90 | 67.02 |
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Zentek Ltd is engaged in developing opportunities in the graphene and related nano-materials industry based on its intellectual property, patents, and Albany graphite. The Company's operating segments are Intellectual Property Development, Biotech, and Albany Project. Intellectual Property Development includes the manufacturing and distribution of graphene-related products. Biotech includes service revenue generated through aptamer technology. The Albany Project includes the exploration and evaluation of assets and mineral exploration activities.